This review highlights the emerging role of long non-coding RNAs as critical regulators in ovarian granulosa cells and their potential clinical utility as biomarkers for female reproductive disorders.
No takes yet. Share an insight, caveat, or question.
LncRNAs may aid ovarian disorder research; leaves open biomarker validation before any clinical role.
Tu et al. (2020) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: